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Introduction
 VLPs present challenges for DSP, thus alternative strategies are desired;
 We evaluated semi-continuous, multicolumn chromatography techniques, that
have the potential to improve process economics;
 A simple serial connection of two chromatographic columns directs the effluent of
one column to an adjacent one, capturing the breakthrough from the previous
column and avoiding product loss;
 This simple setup modification overcomes the limitations of single-column
processes by achieving saturation of the first column;
 It also benefits from the countercurrent flow between the mobile and the
stationary phases, which optimizes the driving force for mass transfer throughout
the overall trajectory of the two phases;
AIM: Evaluate continuous multicolumn 
chromatography for hepatitis C VLP purification
Materials & Methods
Anion exchange resins: two commercially available matrices (Fractogel® TMAE and DMAE)
and three Eshmuno® Q prototypes (1, 2, 3) with different ligand densities (Merck Millipore)
Buffers: 50 mM HEPES at a pH of 7.4 with 0-1 M NaCl
DBC determination for single-column experiments using 1 mL scout columns on ÄKTA
Explorer 10s system. This system was modified to support the multicolumn process operation
Columns used in the multicolumn process were slurry packed with Eshmuno® prototype 1
to a final bed volume of 4 mL
HCV-VLP quantification: ELISA kit targeting the GAG p30 protein of the VLPs capsid
(QuickTiter™MuLV, Cell Biolabs, Inc.)
Total Protein quantification: BCA protein assay kit (Pierce Biotechnology)
Total double stranded DNA quantification: PicoGreen™dsDNA Assay kit (Life Technologies)





Figure 2: Picture of modified ÄKTA Explorer 10s (left) for
implementation of the multicolumn flow schemes (top)
AEX Resin Q1 Q2 Q3 TMAE DMAE
DBC10% 1310 1168 1175 923 917
LD +++++ ++ +++ + +
Figure 3: Frontal experiments for DBC
determination using scout columns (1mL)
Table 1: DBC (ng p30/mL packed resin) for
evaluated AEX resins and relation to ligand density
Eshmuno 1 was selected due to its higher capacity
Figure 1: Steps and materials used for preparation of the HCV-VLP bulk
Single Column Batch Experiments
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Experimental Run
Elution step (mM NaCl) 400 550 700
VLPs Recov. 19 % 35 % 37 %
1 M (NaCl) Elution step Recov. 11 % 5 % 5 %
DNA Remov. 67 % 60 % 53 %
Host cell Prot. Remov. 42 % 33 % 27 %
Total Prot. Remov. 92 % 63 % 46 %
Figure 3: Sequence of steps in Bind & Elute chromatography
Table 2: Summary of experiments to determine optimal buffer
elution conditions; Load up to 90% of column breakthrough
 A step elution with 550 mM of NaCl displayed best compromise between 
recovery and impurity removal;
 Loading below 10% of column breakthrough resulted in lower VLP recoveries 
(< 19%, data not shown);
 Loads of 90% of column breakthrough lead to a loss of VLPs in the 




Final Remarks & Future Work
 Successful implementation of a fully continuous multicolumn
chromatographic step was achieved;
 The used shortcut design method allowed to increase HCV-VLPs
recovery from 35% to 55% without cycle optimization;
 By maintaining the MTZ inside the column loop it was possible to
improve the resin capacity utilization;
 Due to the cyclic exchange of the columns position, the multicolumn
process benefits from the advantageous simulated countercurrent
movement of fluid and solid phases
 Mathematical modelling can be used to further improve cycle design
and optimize both step sequence and duration;
Figure 5: Experimental run of the proposed multicolumn process for continuous
purification of HCV-VLPs; Shaded areas correspond to product collection in column 1;
non-shaded areas correspond to the product collection in column 2;
 In steps i) to iii) the downstream column is loaded up to 10% of
breakthrough, while the upstream column, loaded in the previous
operation cycle follows a sequence of steps similar to a batch
operation;
 The effluent of the downstream column is connected to the previous
column while loading is maintained, thus avoiding the exit of the MTZ
and allowing a 90% of breakthrough column load;
Figure 4: Frontal experiments performed
in the chromatographic beds used for the
multicolumn process (left); Proposed step
sequence for the first half cycle of the
multicolumn process (right); In the second
half-cycle columns exchange position.
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 Similar HCP and total protein clearance was achieved;
 Increased clearance of DNA;
 Increased recovery of HCV-VLPs
Figure 6: Comparison between batch and multicolumn runs
